Fang Wu

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 5

Top Topics

Cell Cycle Arrest

Binding Protein

Top Venues

Cancer biology & therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Zhenyuan Qian, Wenfa Lin, Xufan Cai, Jianzhang Wu, Kun Ke, Zaiyuan Ye, Fang Wu
WYC-209 inhibited GC malignant progression by down-regulating WNT4 through RARα. Cancer biology & therapy 25 (1) (2024)
Zhenyuan Qian, Wenfa Lin, Xufan Cai, Jianzhang Wu, Kun Ke, Zaiyuan Ye, Fang Wu
WYC-209 inhibited GC malignant progression by down-regulating WNT4 through RARα. Cancer biology & therapy 25 (1) (2024)
Zhenyuan Qian, Wenfa Lin, Xufan Cai, Jianzhang Wu, Kun Ke, Zaiyuan Ye, Fang Wu
WYC-209 inhibited GC malignant progression by down-regulating WNT4 through RARα. Cancer biology & therapy 25 (1) (2024)
Zhenyuan Qian, Wenfa Lin, Xufan Cai, Jianzhang Wu, Kun Ke, Zaiyuan Ye, Fang Wu
WYC-209 inhibited GC malignant progression by down-regulating WNT4 through RARα. Cancer biology & therapy 25 (1) (2024)
Zhenyuan Qian, Wenfa Lin, Xufan Cai, Jianzhang Wu, Kun Ke, Zaiyuan Ye, Fang Wu
WYC-209 inhibited GC malignant progression by down-regulating WNT4 through RARα. Cancer biology & therapy 25 (1) (2024)